Lexicon Pharmaceuticals Stock (NASDAQ: LXRX) stock price, news, charts, stock research, profile.
Open | $1.550 |
Close | - |
Volume / Avg. | 116.098K / 4.700M |
Day Range | 1.530 - 1.580 |
52 Wk Range | 0.920 - 3.789 |
Market Cap | $381.815M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 34 |
Short Interest | 45.92% |
Days to Cover | 5.89 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Lexicon Pharmaceuticals (NASDAQ: LXRX) through any online brokerage.
Other companies in Lexicon Pharmaceuticals’s space includes: Skye Bioscience (NASDAQ:SKYE), Precigen (NASDAQ:PGEN), Voyager Therapeutics (NASDAQ:VYGR), Larimar Therapeutics (NASDAQ:LRMR) and PepGen (NASDAQ:PEPG).
The latest price target for Lexicon Pharmaceuticals (NASDAQ: LXRX) was reported by Needham on Tuesday, April 23, 2024. The analyst firm set a price target for 0.00 expecting LXRX to fall to within 12 months (a possible -100.00% downside). 4 analyst firms have reported ratings in the last year.
The stock price for Lexicon Pharmaceuticals (NASDAQ: LXRX) is $1.5506 last updated Today at April 26, 2024 at 9:00 AM EDT.
There are no upcoming dividends for Lexicon Pharmaceuticals.
Lexicon Pharmaceuticals’s Q1 earnings are confirmed for Tuesday, May 7, 2024.
There is no upcoming split for Lexicon Pharmaceuticals.
Lexicon Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.